Moncef Jendoubi, Ph.D.
Founder & CEO
Dr. Jendoubi holds an M.S. in Genetics, an M.S. in Biochemistry, a Ph.D. in Molecular Biology, a “Doctorat D’Etat Es Sciences” in Immunology, and a diploma in Bacteriology from the University of Paris. He trained at the Pasteur Institute, where he held the position of Associate Professor. In 1987, he joined the National Institutes of Health (NIH) as Visiting Professor and became Chief of the Genetics and Molecular Immunology Section in 1990. At the NIH, his research focused on cell-cell communication pathways. He has authored dozens of publications and holds several patents.
Christine Chavany, PhD, RAC,
Director of Operations & Regulatory Compliance
Dr Chavany has led Milagen’s R&D effort in cancer biomarker discovery and development since the inception of the company in 1997. She has been a key figure in the development of all company’s technologies, from antibody screening to biomarker discovery, from monoclonal antibody production to immunoassay development. Dr. Chavany has also been a Principal Investigator in numerous NIH-SBIR-funded projects.
Dr. Chavany oversees the GMP manufacturing of Milagen diagnostic product pipeline and provides guidance in regulatory affairs and compliance, closely working with the Regulatory Team.
Dr. Chavany received her Ph.D. in Pharmaceutical Sciences from the University of Paris XI-Orsay in 1991 and trained at the National Cancer Institute of the NIH from 1991 to 1997 focusing on the anti-cancer activity of antisense oligonucleotides and drugs, and characterization of transgenic mice as a model for neurodegenerative diseases. Prior to joining Milagen, she held Scientist positions in the biotech sector. Dr. Chavany is a member of the American Association for Cancer Research (AACR) and is Regulatory Affair Certified by the Regulatory Affair Professional Society since 2001.
Dr. Merl Arthur Charles M.D. Ph.D
Clinical Laboratory Director
Dr. Merl Charles is an internal medicine provider established in San Francisco, California and his medical specialization is internal medicine (endocrinology, diabetes & metabolism) with more than 55 years of experience. The NPI number of Merl Charles is 1023152055 and was assigned on February 2007. The practitioner’s primary taxonomy code is 207RE0101X with license number G22463 (CA). The provider is registered as an individual and his NPI record was last updated 15 years ago.
An internist like Dr. Merl Arthur Charles Md Phd is a physician who has completed an internal medicine residency and is board-certified or board-eligible in an internist specialty. Internists are trained to care for adults of all ages for many different medical conditions. An internist typically monitors chronic physical conditions, identifies acute diseases, provides family planning, provides counseling about wellness and disease prevention, etc.
Merl Charles is enrolled in PECOS and is eligible to order or refer healthcare services for Medicare patients. The provider is eligible to order or refer: Part B Clinical Laboratory and Imaging, Durable Medical Equipment (DME), a Home Health Agency (HHA) and Power Mobility Devices
Merl Charles is registered with Medicare and accepts claims assignment, this means the provider accepts Medicare’s approved amount for the cost of rendered services as full payment. Participating providers may not charge Medicare beneficiaries more than Medicare’s approved amount for their services. Medicare beneficiaries still have to pay a coinsurance or copayment amount for a visit or service.